Sanjiv K. Patel, M.D.

Sanjiv K. Patel, M.D.

President and Chief Executive OfficeratRelay Therapeutics· In proxies 2021–2025

Pay in FY2025-64% from the year before · Relay Therapeutics stock +105.3% the same year

Sanjiv K. Patel, M.D. was paid $4.6M in FY2025 (Dec), down 64%. Relay Therapeutics stock rose 105.3% that year.

Pay$100 in the stock at the end of FY20 → $20
Pay is from the Summary Compensation Table of each Relay Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Relay TherapeuticsPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role -58%
  2. ARYA Sciences Acquisition Corp VPublic company · 2 yr
    • Director2021 – 2023 · 2 yrNo stock prices for these years
  3. Prothena CorporationPublic company · 2 yr
    • Director2021 – 2023 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?